The DOI matches its Crossref record; 67 of the 73 references it cites were found in a registry or an index.
Brain dopamine transporter levels in treatment and drug naive adults with ADHD
Abstract
Attention deficit hyperactivity disorder (ADHD) is the most frequent psychiatric disorder in children, yet data are sparse on its pathophysiology. Particularly relevant are the dopamine transporters since these are the main targets of stimulant medications used for ADHD treatment. Though some imaging studies have shown increases in dopamine transporters in ADHD others have not and their role in the neurobiology of ADHD remains unclear. Here we investigate dopamine transporters in ADHD subjects with control of potentially confounding factors (previous medication and/or drug histories, comorbidity) and their association with clinical symptoms. Positron emission tomography and [11C]cocaine were used to measure dopamine transporters in 20 never medicated adults with ADHD and 25 controls. Dopamine transporters were lower in left caudate (13%, p < 0.05) and in left nucleus accumbens (p < 0.005) in ADHD subjects than in controls. In putamen dopamine transporters did not differ between groups but were associated with scores of inattention (Conners Adult Attention Rating Scale) both in ADHD subjects (p < 0.005) and in controls (p < 0.005). Thus, for a given transporter level the scores for inattention were on average five times greater in ADHD subjects than in controls. These results do not corroborate increases in dopamine transporters in ADHD subjects and show that in some they are reduced. It also provides evidence that dopamine transporter levels modulate attention but suggest that additional pathology (e.g., prefrontal or cingulostriatal pathways, noradrenergic neurotransmission) is necessary to account for the large differences in inattention observed between controls and ADHD subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of studies have shown that ADHD is associated with a motivational deficit due to a dopamine dysfunction in the basal ganglia [71–73].”
From The brain anatomy of attention-deficit/hyperactivity disorder in young adults—a magnetic resonance imaging study (2017) · cites this paper as [72]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 1×
“However, other factors such as ADHD subtypes or genotypes may also affect DAT (Castellanos and Tannock, 2002; Pliszka et al., 1996).”
BackgroundBiederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Self-citationQuantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
Castellanos, F. X. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070053009 · Cited by 1,183
sagvolden, T., johansen, E. B., aase, H., & russell, V. A. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000075 · Cited by 1,035
Impulsive choice induced in rats by lesions of the nucleus accumbens core
Cardinal, R. N., Pennicott, D. R., Lakmali, C., Sugathapala, Robbins, T. W., & Everitt, B. J. (2001) · Science · doi:10.1126/science.1060818 · Cited by 923
Correction for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919
Self-citationPsychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Self-citationFilipek, P. A., Semrud-Clikeman, M., Steingard, R. J., Renshaw, P. F., Kennedy, D. N., & Biederman, J. (1997) · Neurology · doi:10.1212/wnl.48.3.589 · Cited by 732
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521
Quantitative Brain Magnetic Resonance Imaging in Girls With Attention-Deficit/Hyperactivity Disorder
Castellanos, F. X., Giedd, J. N., Berquin, P. C., Walter, J. M., Sharp, W. S., Tran, T., Vaituzis, A. C., Blumenthal, J. D., Nelson, J. E., Bastain, T. M., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.289 · Cited by 438
Catecholamines in Attention-Deficit Hyperactivity Disorder: Current Perspectives
Pliszka, S. R., McCracken, J. T., & Maas, J. W. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199603000-00006 · Cited by 436
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Imaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Self-citationDopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 377
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373
Critical Involvement of Dopaminergic Neurotransmission in Impulsive Decision Making
van Gaalen, M. M., van Koten, R. C., Schoffelmeer, A. N. M., & Vanderschuren, L. J. M. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.005 · Cited by 338
Konrad, K., Neufang, S., Hanisch, C., Fink, G. R., & Herpertz-Dahlmann, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.013 · Cited by 335
Teicher, M. H., Anderson, C. M., Polcari, A. M., Glod, C. A., Maas, L. C., & Renshaw, P. F. (2000) · Nature Medicine · doi:10.1038/74737 · Cited by 317
Zahniser, N. R., & Doolen, S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00158-9 · Cited by 311
The Nature and Heritability of Attention-Deficit/Hyperactivity Disorder
Faraone, S. V., & Doyle, A. E. (2001) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30059-2 · Cited by 304
Primate cingulostriatal projection: Limbic striatal versus sensorimotor striatal input
Kunishio, K., & Haber, S. N. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500302 · Cited by 290
Mapping cocaine binding sites in human and baboon brain in vivo
Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Logan, J., Bendriem, B., Gatley, S. J., et al. (1989) · Synapse · doi:10.1002/syn.890040412 · Cited by 289
Self-citationVolkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281
Self-citationDresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278
Antidepressants in panic disorder: clinical and preclinical mechanisms.
Conners, C. K. (1998) · PubMed · Cited by 277
Vaidya, C. J., Bunge, S. A., Dudukovic, N. M., Zalecki, C. A., Elliott, G. R., & Gabrieli, J. D. E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1605 · Cited by 269
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
van Dyck, C. H., Malison, R. T., Jacobsen, L. K., Seibyl, J. P., Staley, J. K., Laruelle, M. A., Baldwin, R. M., Innis, R. B., & Gelernter, J. E. (2005) · PubMed · Cited by 257
High Midbrain [ 18 F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder
Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1209 · Cited by 256
Staley, J. K., Krishnan‐Sarin, S., Zoghbi, S. S., Tamagnan, G. D., Fujita, M., Seibyl, J. P., Maciejewski, P. K., O’Malley, S. S., & Innis, R. B. (2001) · Synapse · doi:10.1002/syn.1084 · Cited by 247
Jucaite, A., Fernell, E., Halldin, C., Forssberg, H., & Farde, L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.009 · Cited by 236
Spencer, T. J., Biederman, J., E. Ciccone, P., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., Parasrampuria, D. A., & Fischman, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.387 · Cited by 206
Johansen, E. B., Aase, H., Meyer, A., & Sagvolden, T. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00434-x · Cited by 195
Cheon, K.-A. A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C., & Lee, J. E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1047-3 · Cited by 189
Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185
Logan, J., Volkow, N. D., Fowler, J. S., Wang, G., Dewey, S. L., MacGregor, R. R., Schlyer, D. J., Gatley, S. J., Pappas, N. R., King, P. T., et al. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.132 · Cited by 167
Self-citationCheon, K.-A. A., Ryu, Y. H., Kim, J.-W., & Cho, D.-Y. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.004 · Cited by 162
Malison, R. T., Best, S. E., van Dyck, C. H., McCance, E. F., Wallace, E. A., Laruelle, M. A., Baldwin, R. M., Seibyl, J. P., Price, L. H., Kosten, T. R., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.832 · Cited by 156
Wilson, J., Nobrega, J., Carroll, M., Niznik, H. B., Shannak, K. S., Lac, S., Pristupa, Z. B., Dixon, L., & Kish, S. J. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02966.1994 · Cited by 143
Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
van Dyck, C. H., Quinlan, D. M., Cretella, L. M., Staley, J. K., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.309 · Cited by 139
Clinical foundations of hyperactivity research
Taylor, E. A. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00165-4 · Cited by 134
The dopamine transporter proteome
Torres, G. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03719.x · Cited by 126
Striatal Dopaminergic Abnormalities in Human Cocaine Users
Little, K. Y., Zhang, L., Desmond, T., Frey, K. A., Dalack, G. W., & Cassin, B. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.238 · Cited by 116
Putamen Lesions and the Development of Attention-Deficit/Hyperactivity Symptomatology
Max, J. E., Fox, P. T., Lancaster, J. L., Kochunov, P. V., Mathews, K. D., Manes, F. F., Robertson, B., Arndt, S. V., Robin, D. A., & Lansing, A. E. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00014 · Cited by 114
Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum
Brandon, C. L., & Steiner, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02892.x · Cited by 105
Benke, T., Delazer, M., Bartha, L., & Auer, A. (2003) · Neurocase · doi:10.1076/neur.9.1.70.14374 · Cited by 102
Kaneko, M., Hoshino, Y., Hashimoto, S., Okano, T., & Kumashiro, H. (1993) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01066418 · Cited by 96
Lou, H. C., Rosa‐Neto, P., Pryds, O. A., Karrebæk, H., Lunding, J. M. C., Cumming, P. D., & GJEDDE, A. H. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000313 · Cited by 90
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., Tatsch, K., & Ackenheil, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002821 · Cited by 88
Brain Dopamine Transporter Messenger RNA and Binding Sites in Cocaine Users
Little, K. Y., McLaughlin, D. P., Zhang, L., McFinton, P. R., Dalack, G. W., Cook, E. H., Cassin, B. J., & Watson, S. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.793 · Cited by 76
Ranna, M., Sinkkonen, S. T., Möykkynen, T. P., Uusi‐Oukari, M., & Korpi, E. R. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-1 · Cited by 75
Is increased D2 receptor availability associated with response to stimulant medication in ADHD
Ilgin, N., Şenol, S., Gücüyener, K., Gökçora, N., Atavci, S., & Şener, Ş. (2001) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201001384 · Cited by 75
Viggiano, D., Ruocco, L. A., Arcieri, S., & Sadile, A. G. (2004) · Neural Plasticity · doi:10.1155/np.2004.133 · Cited by 71
Koff, J. M., Shuster, L., & Miller, L. G. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38476-4 · Cited by 65
Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells
Hwang, O., Baker, H. A., Gross, S. S., & JOH, T. H. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199802)28:2 · Cited by 62
Self-citationLarisch, R., Sitte, W., Antke, C., Nikolaus, S., Franz, M., Tress, W., & M??ller, H.-W. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200603000-00010 · Cited by 58
NETO, P. R., LOU, H., CUMMING, P., PRYDS, O., & GJEDDE, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04184.x · Cited by 54
Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
Volkow, N. D., Fowler, J. S., Logan, J., Gatley, S. J., Dewey, S. L., MacGregor, R. R., Schlyer, D. J., Pappas, N. R., King, P., & Wang, G. (1995) · PubMed · Cited by 47
Self-citationSensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine
Gatley, S. J., Volkow, N. D., Fowler, J. S., Dewey, S. L., & Logan, J. (1995) · Synapse · doi:10.1002/syn.890200207 · Cited by 33
Self-citation
Flagged first, then by citations
6 of the 73 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Conners, 1998, Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring, J. Clin. Psychiatry, 59, 24
- Hesse, 2006, The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder, J. Nucl. Med., 47, 142
- National Institutes of Health (NIH), 2000, Consensus Development Conference Statement: diagnosis and treatment of attention deficit/hyperactivity disorder (ADHD), J. Am. Acad. Child Adolesc. Psych., 39, 192
Cited by
Sorted by citations
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Self-citationInsights into the neural basis of response inhibition from cognitive and clinical neuroscience
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.016 · Cited by 938
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“Fronto-striatal dysfunction and increased dopamine transporter density in the striatum have both been reported [83-86] although the finding of increased dopamine transporter density remains a controversial finding, perhaps secondary to drug treatments for ADHD [87,88].”
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728
Self-citationUpdated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
Metadata
- Authors
- Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., Schulz, K., & Pradhan, K.
- Affiliations
- National Institute on Drug Abuse (US)
- Brookhaven National Laboratory (US)
- Mount Sinai Hospital (US)
- National Institute on Alcohol Abuse and Alcoholism (US)
- University of California, Irvine (US)
- State University of New York (US)
- Corresponding author
- Volkow, Nora D.
- ORCID
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 34
- Issue
- 3
- Pages
- 1182-1190
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2082738856
- Cited by
- 249
- References
- 73
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 4 · 2018: 12 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 24 · 2013: 14 · 2012: 22
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- NeuroImage (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (MH66961-02, R01MH066961)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, dopamine transporter, caudate nucleus, nucleus accumbens, putamen, inattention, adult ADHD, neurobiology of ADHD, noradrenergic neurotransmission
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Carbon Radioisotopes, Cocaine, Female, Humans, Male, Tissue Distribution, Radiopharmaceuticals, Positron-Emission Tomography, Dopamine Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review